Table of contents

Electronic pages

• THUR 001 An unusual (ne)urological presentation (13 September, 2018)

  Stevenson Alexander, Yoganathan Katie, Gleeson David, Singh Ravneeta
• THUR 002 An unusual presentation: two aetiologies for the price of one! (13 September, 2018)

  Yoganathan Katie, Stevenson Alexander, Khoylou Sanam, Pearce Ronald
• THUR 004 Foramen magnum decompression for tonsillar herniation secondary to meningoencephalitis (13 September, 2018)

  Wysota Barbara, Afshari Fardad, Oswall Michelle, Mazibrada Gordon, White Edward
• THUR 005 Two atypical presentations of pres? (13 September, 2018)

  Lowry Andrew, Das Joyutpal, Price Siân
• THUR 006 A case of GABA-B antibody mediated encephalopathy (13 September, 2018)

  Abdel-Mannan Omar, Harikrishnan Seeedharan, Abdel-Aziz Khaled
• THUR 007 A garden variety neuropathy (13 September, 2018)

  Salini Sumangala, Ben Simpson, Jithin George
• WED 011 Subacute combined degeneration of the cord: laugh until you are weak (13 September, 2018)

  Francis Anna, Matar Maz
• WED 012 Reversible optic neuritis secondary to metronidazole (13 September, 2018)

  Anwyll Natalie, Gerry Paul, Gormley Kevin
• WED 014 Oct minimises unnecessary investigation for suspected papilloedema (13 September, 2018)

  Coysh Thomas, Whiteside David, Williamson Sarah, Muhammed Louwai, Metta Vinod, Geranmayeh Fatemeh, Seemungal Barry, Gabriel Carolyn, Ball Joanna, Nicholas Richard
• WED 016 A service evaluation of the acute neurology clinic (13 September, 2018)

  Wynford-Thomas Ray, Johnston Ann
• WED 017 Call on me: expanding the consultant advice line for gps (13 September, 2018)

  Ellis Richard, James Booth, Riley Julie, Duffy Jen, Wilson Martin
• THUR 018 Advice and guidance: not so quick and easy (13 September, 2018)

  Kipps Christopher, Delves Sarah, Burke Georgina, Halfpenny Christopher, Kitley Joanna, Frankel Jonathan, Slaght Sean, Gibb William
• THUR 021 Transforming acute neurology: a 4 year study (13 September, 2018)

  Nitkunan Arani, Macdonald Bridget, Bhoodoo Ajay, Southam Medina, Smyth Caitlyn, Tomkins Andrew, Schon Fred
• WED 024 Acute model in gloucestershire (13 September, 2018)

  Ball Harriet, Bosnell Rose, Fuller Geraint
• WED 026 ‘creating a neurological exam template for acute medical admissions’ (13 September, 2018)

  McMullan Kieran, Redmond Janice
• WED 027 Acute neurology in glasgow (13 September, 2018)

  Brennan M, Tyagi A, Leach JP
• WED 028 One person can make a difference: our experience in a busy london dgh (13 September, 2018)

  Aadila Lalloo, Bazo Raheem, Giovanni Cocco, Ana Guzman, Michael Rose, Flavia Niccolini, Eli Silber
• WED 031 Neuro hot clinics: direct access clinic for acute medical patients (13 September, 2018)

  Clifford Z, Morrish P, Strait C, Hinze S
• WED 033 Minimum prevalence of non-compliance recorded in an audit of antenatal care in a district general hospital joint obstetric epilepsy (13 September, 2018)

  Smyth C, Gornall A, Bowen J
• THUR 037 Identification of biofluid markers of TDP-43 pathology (13 September, 2018)

  Shafei Rachelle, Foiani Martha, Heller Carolin, Heslegrave Amanda, Woollacott Ione, Dick Katrina, Warren Jason, Schott Jonathan, Zetterberg Henrik, Rohrer Jonathan
• THUR 051 Ictal asystole: return to the history (13 September, 2018)

  Mbizvo Gashirai, Derry Chris, Davenport Richard
• THUR 052 Epilepsy in the land of ice and fire (13 September, 2018)

  Wojtowicz Alex L, Thomas Rhys H
• THUR 054 The heart holds answers the brain cannot to see (13 September, 2018)

  Williams Owain, Hu Mo, Changaradil Deepthi, Fry Andrew, Powell Robert
• THUR 056 Juvenile myoclonic epilepsy in a tertiary centre – a database review (13 September, 2018)

  Edwards Marc, Smith PEM, Hamandi Khalid
• THUR 058 Eslicarbazepine acetate as monotherapy in clinical practice (13 September, 2018)

  McMurray Rob, Delanty Norman, Villanueva Vicente
• WED 061 ‘real life’ experience with brivaracetam as add-on treatment for epilepsy (13 September, 2018)

  Hughes Rhiannon, Maguire Melissa, Geldard Jo, Reuber Markus
• WED 063 Eslicarbazepine acetate switch from carbamazepine or oxcarbazepine (13 September, 2018)

  Peltola Jukka, McMurray Rob, Villanueva Vicente
• WED 066 Web-based media as a self-management tool for people with epilepsy (13 September, 2018)

  McKinlay Alison, Ridsdale Leone
• THUR 071 Towards an integrated tool for pnes assessment (13 September, 2018)

  d’Ersu Eleanor, Al-Mayhani Talal, Sidhu Meneka
• THUR 075 Evaluating a personal information pack in epilepsy (13 September, 2018)

  Edmond Evan, Mehta Arpan, Taylor Alison, Jacob John
• WED 078 ‘not just a headache’: social media use in people with migraine (13 September, 2018)

  Ridsdale Leone, Swindale Rosanna, Keighley Peter, Pearson Carly
• WED 079 Epidural blood patch: impact of non-luer one-way butterfly needle (13 September, 2018)

  Mahmood Asif, Sharpe Paul
• WED 080 Experiences of specialist referral and GP access to MRI for headache (13 September, 2018)

  McKinlay Alison, Underwood Raphael, Mazumder Asif, Kilner Rachael, Ridsdale Leone
• THUR 084 Cranial autonomic symptoms in cluster headache induced by nitroglycerin (13 September, 2018)

  DY Wei, PJ Goadsby
• THUR 090 Idiopathic intracranial hypertension – towards a streamlined pathway (13 September, 2018)

  Vijay Vivek, Grant Laura, Nagar Anindyt, Bahra Anish
• WED 094 Diagnostic error rates in diagnosing idiopathic intracranial hypertension (13 September, 2018)

  Scotton Sangeeta, Liczkowski Anthony, Mollan Susan P, Sinclair Alexandra J
• WED 097 Diagnostic lumbar punctures in IIH: what is the patient experience? (13 September, 2018)

  William J Scotton, Susan Mollan, Thomas Walters, Sandra Doughty, Peter Nightingale, Hannah Botfield, Keira Markey, Andreas Yiangou, Shelly Williamson, Alexandra Sinclair
• THUR 101 SCA-1 with unusual early dysautonomia and delayed cerebellar signs (13 September, 2018)

  d’Ersu Eleanor, Anwar NurAizaan, Al-Mayhani Talal, Sidhu Meneka
• THUR 103 Chorea associated with atrial myxoma (13 September, 2018)

  Healy Sarah, Ellis Richard James Booth, Steiger Malcolm
• THUR 104 Global MD registry and dystonia non-motor symptoms study (13 September, 2018)

  Yilmaz Zehra, Peall Kathryn
• WED 106 Unilateral abnormal dat scan: early indicator of parkinson’s disease (13 September, 2018)

  Heng Nicholas, Chin Mei Ying, Monaghan Clare, Davidson John, Gilbertson Tom, Muqit Miratul
• WED 109 Computer vision: a smartphone camera can ‘see’ bradykinesia (13 September, 2018)

  Williams Stefan, Fang Hui, Qahwaji Rami, O’Gorman Paschal, Patel Parisa, Graham Christopher D, Alty Jane
• WED 112 Seeing invisible parkinsonian tremor with a smartphone camera (13 September, 2018)

  O’Gorman Paschal, Williams Stefan, Fang Hui, Qahwaji Rami, Patel Parisa, Graham Christopher D, Alty Jane
• WED 114 Pathways to diagnosis in PSP, CBD and PD (13 September, 2018)

  Swallow Diane, Counsell Carl
• THUR 116 Vascular prevention in patients with parkinson’s disease (13 September, 2018)

  Kempe Isla, Grosset Katherine A, Grosset Donald G
• THUR 117 The L-DOPA response in pathologically confirmed parkinson’s disease (13 September, 2018)

  Vanessa Pitz, Naveed Malek, Katherine A Grosset, Donald G Grosset
• THUR 120 Postprandial hypotension in MSA and PD with autonomic failure (13 September, 2018)

  Vichayanrat Ekawat, Ingle Gordon, Hagen Ellen Merete, Mathias Christopher, Iodice Valeria
• THUR 121 Identifying participants with parkinson’s disease in uk biobank (13 September, 2018)

  Bush Kathryn, Rannikmae Kristiina, Schnier Christian, Wilkinson Timothy, Nolan John, Bennett Michael, Cheng Jingjie, Sudlow Cathie, et al
• THUR 122 Parkinson’s kinetigraph improves movement disorder service provision (13 September, 2018)

  Kobylecki Christopher, Partington-Smith Lucy, Silverdale Monty
• WED 127 Update on the questionnaire for brain donors at queen square brain bank (13 September, 2018)

  Yoganathan Katie, Barbosa Pedro, Noyce Alastair, Fernandez Eduardo, Shaw Karen, Ling Helen, Hansen Daniela, Warner Tom, Lees Andrew
• WED 128 Care and unmet needs in late-stage parkinsonism: a qualitative study (13 September, 2018)

  Read Joy, Cable Sarah, Löfqvist Charlotte, Iwarsson Susanne, Bartl Gergely, CLaSP consortium, Schrag Anette
• WED 129 Improving community exercise provision in parkinson’s (13 September, 2018)

  Madeleine Palin, Jane Rideout, Camille Carroll, Valerie Evans
• WED 130 Designing a care pathway for high risk parkinson’s patients (13 September, 2018)

  Tam Lok Yee Chloe, Thea Dominey, Emma Pearson, Fiona Murphy, Camille Carroll
• WED 131 Evaluating the clinical utility of the parkinson’s kinetigraph (PKG) (13 September, 2018)

  Lewis Hutchinson, Thea Dominey, Emma Pearson, Fiona Murphy, Lucy Bell, Camille Carroll
• THUR 132 Neuroschistosomiasis: complication of a neglected tropical disease (13 September, 2018)

  Joe Dorothy, Boyle Thomas, Roy Amit, Leschziner Guy, Evans Matthew
• THUR 134 Isolated CNS histoplasmosis in an immunocompetent patient (13 September, 2018)

  Jaffer Fatima, Glass Stephen, Silber Eli, Sibtain Naomi, Bicanic Tihana, Nashef Lina
• WED 139 Gene expression regulation in CD4+ t-cell dysfunction in ms (13 September, 2018)

  Hrastelj James, Bray Nicholas, Williams Nigel, Robertson Neil
• WED 141 Pathological correlates of age at death in multiple sclerosis (13 September, 2018)

  Geraldes Ruth, Esiri Margaret, Palace Jacqueline, DeLuca Gabriele
• WED 142 ‘anti-hu syndrome’ – a case of paraneoplastic sensory neuropathy with encephalitis (13 September, 2018)

  Gupta Srishti, Jaiswal Amit, Knopp Michael
• WED 143 Chronic relapsing inflammatory optic neuritis (CRION) in the neuroinflammatory clinic (13 September, 2018)

  Cousins Oliver, Khan Hina, Harikrishnan Sreedharan
• WED 145 Human T-lymphotropic virus (HTLV)-associated encephalitis (13 September, 2018)

  Crawshaw Ania, Dhasmana Divya, Gabriel Carolyn, Jones Brynmor, Sturman Steve, Davies Nick, Taylor Graham
• WED 148 Imaging findings in autoimmune encephalitis: a retrospective review (13 September, 2018)

  Fazal Jawad, Sadiq Nouman, Bowen Michael, Muhammad Wasim Wali, Sawlani Vijay, Jacob Saiju
• THUR 149 ANCA/MPO vasculitis presenting with bilateral ischaemic optic neuropathy (13 September, 2018)

  Mehta Dwij, Wade Charles
• THUR 150 Treatment and outcomes in primary angiitis of the CNS (PACNS) (13 September, 2018)

  Chua Wei Xin, Whittam Dan, Huda Saif, Jacob Anu
• THUR 153 Antibodies against the voltage-gated potassium channel complex (13 September, 2018)

  Joyutpal Das, Vanisha Chauhan, Ryan Keh, Daniel Mills, Johal Nicholas, Rachael Matthews, James Lilleker, David Gosal, Nazar Sharaf
• THUR 154 NMDAR-AB encephalitis: frequency of diagnosis and outcomes (13 September, 2018)

  Lim H, Whittam D, Jackson E, Williams N, O’Connell D, Chadwick C, Keir G, Huda S, Jacob A
• THUR 155 Autonomic function testing in autoimmune autonomic ganglionopathies (13 September, 2018)

  Vivekanandam Vinojini, Vichayanrat Ekawat, Skeavington Ian, Almeida Nadine, Iodice Valeria, Hagen Ellen Merete, Ingle Gorgon
• THUR 156 Safe prescribing of immunosuppression: quality improvement project (13 September, 2018)

  Bush Kathryn, Smith Vivien, Maxwell Gemma, Archibald Neil
• THUR 158 Susac’s syndrome: treatment and outcomes in three cases (13 September, 2018)

  Chua Wei Xin, Whittam Dan, Huda Saif, Rog David, Wilson Martin, Smith David, Enevoldson Peter, Jacob Anu
• THUR 159 Radiological findings in two patients with autoimmune GFAP astrocytopathy (13 September, 2018)

  White Daniel, Patel Markand, Muhammad Wasim, Hayton Tom, Ramalingam Satheesh, Sawlani Vijay, Jacob Saiju
• WED 162 Cognitive impairment in a greek ms patient cohort using bicams (13 September, 2018)

  Kalatha T, Koutsouraki E, Arnaoutoglou M
• WED 163 Monitoring for outcome assessment and trial recruitment of pwms (13 September, 2018)

  Allen-Philbey Kimberley, Turner Ben, Yildiz Ozlem, Mathews Joela, Giovannoni Gavin, Schmierer Klaus
• WED 164 EQ-5D in the assessment of relapse recovery in ms (13 September, 2018)

  Ray Wynford-Thomas, Katharine Harding, Annie Hawton, Claire Hirst, Emma Tallantyre, Colin Green, Neil Robertson
• WED 165 The management of cognitive and behavioural symptoms in ms (13 September, 2018)

  Onwuneme Gloria, Hayat Tayyib TA, Hosseini Akram A
• WED 167 Socioeconomic status and progression of disability in ms (13 September, 2018)

  Katharine Harding, Elaine Kingwell, Mark Wardle, Feng Zhu, Neil Robertson, Helen Tremlett
• WED 168 Blood-brain barrier imaging with dynamic contrast-enhanced mri (13 September, 2018)

  Varatharaj Aravinthan, Liljeroth Maria, Darekar Angela, BW Larsson Henrik, Galea Ian, P Cramer Stig
• WED 170 The utility of brain FDG-PET in a patient with natalizumab associated PML-IRIS (13 September, 2018)

  Baheerathan Aravindhan, Kalam Sabrina, Grote Helen, Mcnamara Cillian, Rane Neil, Nicholas Richard
• THUR 171 Natalizumab effectiveness and safety in top uk patients (13 September, 2018)

  Nicholas Richard, Rosales Karen, Licata Stephanie, Syed Farooq Syed Feisal, Smethurst Caroline
• THUR 172 Phase iv study of cladribine tablets and quality of life: clarify-ms (13 September, 2018)

  S Schippling, D Langdon, A Solari, B Brochet, R Hupperts, F Piehl, J Lechner-Scott, X Montalban, B Keller, N Alexandri
• THUR 173 Longterms: 10-year experience of fingolimod in RRMS patients (13 September, 2018)

  Cohen Jeffrey, Tenenbaum Nadia, Bhatt Alit, Pimentel Ron, Kappos Ludwig
• THUR 174 The magnify-ms study: mavenclad® tablets in active rms (13 September, 2018)

  N de Stefano, A Achiron, F Barkhof, A Chan, T Derfuss, S Hodgkinson, L Leocani, X Montalban, A Prat, K Schmierer, F Sellebjerg, P Vermersch, H Wiendl, B Keller, S Roy
• THUR 177 Efficacy of alemtuzumab retreatment after 2 initial courses (13 September, 2018)

  Sharrack Basil, Singer Barry, Boster Aaron, Bass Ann, Berkovich Regina, Comi Giancarlo, Fernández Óscar, Kim Ho Jin, Limmroth Volker, al et, on behalf of the CARE-MS II and CAMMS03409 Investigators
• THUR 178 Infections during grade 3/4 lymphopenia with cladribine tablets (13 September, 2018)

  Stuart Cook, Thomas Leist, Giancarlo Comi, Xavier Montalban, Elke Sylvester, Christine Hicking, Fernando Dangond
• THUR 179 Ocrelizumab effect on neda in patient subgroups of opera I and opera II (13 September, 2018)

  Turner Ben, Papeix Caroline, Cree Bruce, Kappos Ludwig, Montalban Xavier, Wolinsky Jerry, Buffels Regine, Han Jian, Hauser Stephen
• THUR 180 Patient support program for RRMS patients treated with DMF (13 September, 2018)

  Monterroso Joana, Curlis Janette, Gribben Leontia
• WED 181 Switching early from oral DMT to fingolimod in RRMS patients (13 September, 2018)

  Ziemssen Tjalf, Silva Diego, Medin Jennie, Cornelissen Christian, Ringwald Kathrin, Cohan Stanley
• WED 182 Cladribine tablets effects on lymphocytes in ms patients (13 September, 2018)

  Per Soelberg-Sorensen, Fernando Dangond, Christine Hicking, Gavin Giovannoni
• WED 183 Cladribine tablets effects on t cell subsets in patients with early ms (13 September, 2018)

  Olaf Stuve, Per Soelberg-Sorensen, Thomas Leist, Yann Hyvert, Doris Damian, Ursula Boschert
• WED 184 Cladribine tablets in clarity patients with high disease activity ms (13 September, 2018)

  Gavin Giovannoni, Kottil Rammohan, Stuart Cook, Giancarlo Comi, Peter Rieckmann, Per Soelberg-Sorensen, Patrick Vermersch, Fernando Dangond, Christine Hicking
• WED 185 Clarity: mri outcomes in high disease activity relapsing ms (13 September, 2018)

  Gavin Giovannoni, Kottil Rammohan, Stuart Cook, Giancarlo Comi, Peter Rieckmann, Per Soelberg-Sorensen, Patrick Vermersch, Fernando Dangond, Christine Hicking
• WED 186 Effect of cladribine tablets on immune cells in patients with ms (13 September, 2018)

  Olaf Stuve, Per Soelberg-Sorensen, Gavin Giovannoni, Thomas Leist, Yann Hyvert, Doris Damian, Ursula Boschert
• WED 187 Infections in ocrelizumab recipients from phase III studies (13 September, 2018)

  Giovannoni Gavin, Hartung Hans-Peter, Comi Giancarlo, de Seze Jérôme, Hemmer Bernhard, Kappos Ludwig, Montalban Xavier, Selmaj Krzysztof, Mairon Nicole, Wolinsky Jerry
• WED 188 Pangaea 2.0 interim results: switching to fingolimod (13 September, 2018)

  Cornelissen Christian, Ziemssen Tjalf, Kern Raimar
• WED 190 Teriflunomide pregnancy registry: design and enrolment (13 September, 2018)

  Rog David, Lebrun-Frenay Christine, Seferta Nicola, Benamor Myriam, Colilla Susan, Truffinet Philippe, Ghezzi Angelo
• THUR 192 Yearly lymphopenia rates in cladribine tablets-treated rms patients (13 September, 2018)

  Stuart Cook, Giancarlo Comi, Gavin Giovannoni, Peter Rieckmann, Per Soelberg-Sorensen, Patrick Vermersch, Fernando Dangond, Christine Hicking
• THUR 193 Alemtuzumab improves disability across functional systems (13 September, 2018)

  Sharrack Basil, Hunter Samuel, Aburashed Rany, Alroughani Raed, Dive Dominique, Izquierdo Giullermo, Kim Ho Jin, Lycke Jan, Macdonell Richard
• THUR 194 Autologous haematopoietic stem cell transplant in ms (13 September, 2018)

  Das Joyutpal, Snowden John, Mistry Sona, Bell Simon, Jessop Helen, Sharrack Basil
• THUR 196 Pregnancy outcomes in alemtuzumab-treated rrms patients (13 September, 2018)

  Rog David, Oh Jiwon, Chambers Christina, Hellwig Kerstin, McCombe Pamela, Chung Luke, Daizadeh Nadia, Compston D Alastair S
• THUR 198 Safe monitoring of natalizumab therapy in multiple sclerosis (13 September, 2018)

  Hosty J, Kass-Iliyya L, Bell S, Barker L, Packwood S, Stanislawska A, Hoggard N, Raza M, Paling D
• THUR 199 MS DMT monitoring according to abn guidelines & product specification (13 September, 2018)

  E Carter, MA Macleod, E Visser
• WED 201 A novel KIF1A mutation causing a neurodevelopmental disorder (13 September, 2018)

  Day Jacob, Turnpenny Peter, Gutowski Nick
• WED 202 Lamb-shaffer syndrome: importance of snp array in diagnosing neurodevelopmental syndromes (13 September, 2018)

  Ela M Akay, Ian S Schofield, Ming H Lai, Rhys H Thomas
• WED 203 Vanishing white matter disease due to variant mutations in the EIF2B- 1 gene (13 September, 2018)

  Bangalore Priya, Berry Ian R, Livingston John, Warren Dan, Nicholl David J, O’ Driscoll Mary, Hayton Tom
• WED 209 A case report of hyperhomocystinemia due to homozygous MTHFR mutation (13 September, 2018)

  Afzal Saadia, Hayton Tom, Newman Piers, Dawson Charlotte, O’Driscol Mary
• THUR 213 An unusual case of cluster acetylcholine receptor antibody positive myasthenia gravis (13 September, 2018)

  Kavanagh Conor, Lilleker James, Mohanraj Rajiv, Smith Thomas
• THUR 215 Lessons in the diagnosis and management of poems syndrome (13 September, 2018)

  Adams-Carr Kerala, Keddie Stephen, Lunn Michael
• THUR 216 Myasthenia gravis, thymoma and good’s syndrome (13 September, 2018)

  Elands Sophie, Ingle Gordon
• THUR 217 Salmonella gives you wings (13 September, 2018)

  Kapoor Mahima, M Reilly Mary, J Devine Michael, Carr Aisling
• THUR 219 Myopathic manifestations in haematological conditions (13 September, 2018)

  Vivekanandam Vinojini, Devine H, Holton J, Jaunmuktane Z, Turner C, Machado P, Manji H, McNamara C, D’Sa S, Carr A
• THUR 220 To c or not to c (13 September, 2018)

  Menelaos Pipis, Zane Jaunmuktane, Sebastian Brandner, Shirley D’Sa, Teresa Marafioti, Sachit Shah, Geraint Fuller, Mary M Reilly
• WED 222 Hawkes sign: a novel test for carpal tunnel syndrome (13 September, 2018)

  Hawkes Christopher
• WED 223 Predicting disease activity in inflammatory neuropathies (13 September, 2018)

  Kapoor Mahima, Carr Aisling, Lunn Michael, M Reilly Mary
• WED 224 Building causality networks for inherited neuropathies (13 September, 2018)

  Tiet May Yung, Barnes Michael R
• WED 225 Changing epidemiology of motor neurone disease in scotland (13 September, 2018)

  Leighton Danielle, Chandran Siddharthan, Consortium CARE-MND
• THUR 229 Inertial sensors improve traditional gait monitoring in HSP patients (13 September, 2018)

  McNamara Mary, Segamogaite Ruta, Shaw Pamela, McDermott Christopher, Mazzá Claudia, Hewamadduma Channa
• THUR 231 Developing a new rating scale for ocular myasthenia gravis (13 September, 2018)

  Sui H Wong, Eduardo Miranda, Helena Lee, Eric Eggenberger, Wayne Cornblath, Carolina Barnett
• WED 236 Skeletal muscle channelopathies and sudden infant death syndrome (13 September, 2018)

  Matthews Emma, Mannikko Roope, Wong Leonie, Kullmann Dimitri, Sisodiya Sanjay, Fleming Peter, Behr Elijah, Hanna Michael
• WED 237 Phosphorodiamidate morpholino oligomers for treatment of duchenne muscular dystrophy (13 September, 2018)

  Maresh Kate, Tiet May, Guglieri Michela, Domingos Joana, Straub Volker, Voit Thomas, Muntoni Francesco
• WED 238 Do we follow the abn myaesthenia guidelines? (13 September, 2018)

  Roelofs Jacob, Bosnell Rose, Fuller Geraint
• WED 240 An audit of unplanned admissions in myasthenia gravis patients (13 September, 2018)

  Talaei M, Burke G
• WED 241 Clinical relevance of regular blood monitoring in IG treatment (13 September, 2018)

  A Khalil, L Compton, M Kapoor, J Groves, L Nihoyannopoulos, D Gosal, A Rossor, MM Reilly, AS Carr, T Lavin
• WED 242 A challenging case of periorbital swelling (13 September, 2018)

  Spanoulis Aginor, Yalatia Papastergiou, Panagiota Mitropoulou, Georgina Burke
• WED 243 Enhancing our knowledge of leptomeningeal disease – a case of DL-GNT (13 September, 2018)

  Edwards Marc, Lammie Alistair, Patel Chirag, Schwarz Stefan, Wardle Mark
• WED 244 CSF cytology alone is unable to predict CNS neoplastic process (13 September, 2018)

  Osborne Alex, Hewamadduma Channa
• WED 253 An atypical presentation of sneddon syndrome (13 September, 2018)

  Jonathan Cleaver, Shelley Renowden, Mario Teo, Philip Clatworthy
• WED 255 SSRIS and risk of intracranial haemorrhage (13 September, 2018)

  Melanie P Jensen, Oliver J Ziff, Gargi Banerjee, Gareth Ambler, David J Werring
• WED 258 Stroke mimic diagnoses on a centralised hyperacute stroke pathway (13 September, 2018)

  James D Stefaniak, Rosie Heartshorne, Martin Punter, Jane Molloy
• WED 259 The challenge of mood and cognition screening in hasu (13 September, 2018)

  Harkness Kirsty, O’Malley Ronan, Pratt Gary
• WED 260 Time to scan: barriers to imaging outside normal working hours (13 September, 2018)

  Hosty Jennifer, Bunn Jonathan, Bainbridge Rachel, Dunn Geoffrey, Endean Keith, Harkness Kirsty
• WED 261 Stroke scan agnosia – what radiologists do not see (13 September, 2018)

  McCarron Mark, McKee Jacqueline, Wade Carrie, McVerry Ferghal
• THUR 262 Diagnosis of osas in neurology outpatients (13 September, 2018)

  Shukla Aayushi, Coebergh
• THUR 263 5 year review of our specialist obstetric-neurology clinic (13 September, 2018)

  Kamourieh Salwa, Dhanjal Mandish K, Dassan Pooja
• THUR 264 Multimodal intervention to improve lumbar puncture (13 September, 2018)

  Tobert Vanessa, Allen James, Edmond Evan
• THUR 265 Complaints from patients with functional disorders (13 September, 2018)

  Bolton Clare, Goldsmith Paul
• WED 268 Improving junior doctors induction: queen square junior doctors handbook (13 September, 2018)

  Al-Mayhani Talal, Khalil Aytakin
• WED 270 Optician’s diagnosis of papilloedema impact hospital admissions (13 September, 2018)

  Williamson Sarah, Whiteside David, Coysh Thomas, Metta Vinod, Geranmayeh Fatima, Everitt Alex, Gabriel Carolyn, Seemungal Barry, Ball Joanna, Nicholas Richard
• WED 273 Wessex healthlines: neuroline (13 September, 2018)

  Lillistone Pauline, Chappell Rachel, Dukes Charlie, Higenbottam David, Kipps Christopher
• 274 Exome analysis to investigate autosomal dominant vasovagal syncope (13 September, 2018)

  Aaron Jesuthasan, Michael Keogh, Patrick Chinnery
• 275 Poster: acute neurology care model – ‘the neuro network’ (13 September, 2018)

  Nick Fletcher
• 276 A new face for an old foe? (13 September, 2018)

  Sangha Gavinda, Bron Anthony, Donaghy Michael, Evans Cerys, Hardcastle Alison, Talbot Kevin
• 277 Disentangling corticobasal syndrome from corticobasal degeneration (13 September, 2018)

  Lamb Ruth, Rohrer Jonathan, Lubbe Steven, Weil Rimona, Lashley Tammaryn, Holten Janice, Revesz Tamas, Lees Andrew, Morris Huw
• 278 Inspector norse (13 September, 2018)

  Ross Russell Amy, Massey Luke, Williams Imogen, Fabian Mark, Nicoll James, Eren Efrem, Pelosi Emmanuela, Prevett Martin, Hell James, Katifi Haider
• 279 Apraxia and the temporal lobe in action: a role for biological motion (13 September, 2018)

  Rounis Elisabeth, Pizzamiglio Gloria, Kolasinski James, Riddoch Jane, Mantini Dante, Passingham Richard E
• 280 A screening questionnaire for transient loss of consciousness (13 September, 2018)

  Wardrope Alistair, Jamnadas-Khoda Jenny, Broadhurst Mark, Grünewald Richard A, Howell Stephen J, Koepp Matthias, Parry Steve, Sisodiya Sanjay, Walker Matthew, Reuber Markus
• 281 Predicting neurodegeneration after traumatic brain injury (13 September, 2018)

  Graham Neil SN, Jolly Amy E, Bourke Niall J, Scott Gregory, Cole James H, Sharp David J
• 282 Skull base dural AVF mistaken as cervical myelitis: a series (13 September, 2018)

  Whittam Dan, Huda Saif, Pulicino Richard, Chandran Arun, Puthuran Mani, Jacob Anu
• 283 Quantifying muscle amyloid in inclusion body myositis using pet (13 September, 2018)

  Lilleker James B, Hodgson Richard, Roberts Mark E, Herholz Karl, Howard James, Hinz Rainer, Chinoy Hector
• 284 Acute neurology in aneurin bevan university health board (13 September, 2018)

  Joe Anderson
• 285 Piloting and implementing an acute neurology service (13 September, 2018)

  Thomas Peukert
• 286 Hyperacute stroke unit and hyperacute neurology unit under one roof (13 September, 2018)

  Joyutpal Das, Stefan McKenzie, Paul Gozzard, Michael Pattrick, Ronan O’Malley, Thomas Payne, Richard Grunewald, Kirsty Harkness
• 287 A new UK reproductive care pathway for women with serious MTDNA disease (13 September, 2018)

  Gorman Grainne, McFarland Robert, Stewart Jane, Feeney Catherine, Herbert Mary, Heslop Louise, Blakeley Emma, Taylor Robert, Murphy Julie, Turnbull Doug
• 288 Challenges in reducing hospital deaths in multiple sclerosis (13 September, 2018)

  Nicholas Richard, Nicholas Emma, Koffman Jonathan
• 289 MRI abnormalities in mog antibody disease (13 September, 2018)

  Huda S, Amal Al-Orainy, Anita Saldanha, Whittam D, Christine Denby, Lekha Pandit, Bhojak M, Jacob A
• 290 CSF chitinases as novel biomarkers for MND (13 September, 2018)

  Thompson Alexander G, Gray Elizabeth, Thézénas Marie-Laetitia, Charles Philip D, Evetts Samuel, Hu Michele T, Talbot Kevin, Fischer Roman, Kessler Benedikt M, Turner Martin R
• 291 St george’s hyperacute neurology: right person, right time (13 September, 2018)

  Moodley Kuven, Jones Valerie, Yogarajah Mahinda, Samra Kiran, Vivekananda Umesh, Foster Oliver, Pereira Anthony, Cluckie Gillian, Nirmalananthan Niranjanan
• 292 Mapping patient pathways for acute functional neurological symptoms (13 September, 2018)

  Southall Clea, Haley Samantha, Williams Stefan, Graham Christopher D, Alty Jane, Johnson Owen, Maguire Melissa
• 293 Autoimmune autonomic ganglionopathy: the NHNN experience (13 September, 2018)

  Koay Shiwen, Lang Bethan, Ingle Gordon, Hagen Ellen Merete, Mathias Christopher, Watson Laura, Lunn Michael, Bremner Fion, Vincent Angela, Iodice Valeria
• 294 Neurofilament light protein as a biomarker for huntington’s disease (13 September, 2018)

  Byrne Lauren, Rodrigues Filipe, Johnson Eileanoir, Solyu Kucharz Rana, Gregory Sarah, Scahill Rachael, Björkqvist Maria, Zetterberg Henrik, Tabrizi Sarah, Wild Edward
• 295 Clinical outcome in mog-antibody disease: a large single site cohort (13 September, 2018)

  Messina Silvia, Jurynczyk Maciej, Woodhall Mark R, Tackley George, Chandratre Saleel, Hemingway Cheryl, Waters Patrick, Leite Maria Isabel, Palace Jacqueline
• 296 Longitudinal measurement of serum NFL in early familial AD (13 September, 2018)

  Weston Philip, Poole Teresa, Ryan Natalie, Liang Yuying, Mead Simon, Blennow Kaj, Rossor Martin, Schott Jonathan, Zetterberg Henrik, Fox Nick
• 297 Genetic associations of ICD in parkinson’s disease (13 September, 2018)

  Rees Richard, Hubbard Leon, Ben-Shlomo Yoav, Grosset Donald, Williams Nigel, Morris Huw
• 298 Neurosarcoidosis – review of 91 patients from three UK neuroscience centres (19 October, 2018)

  Farwana Reem, Murley Alex, Ankrah Lauren, Whittam Dan, Hayton Tom, Jacob Anu, Constantnescu Cris, Jacob Saiju
• 299 Immune-dysregulation in late onset myasthenia gravis (19 October, 2018)

  Sadalage Girija, Jacob Saiju, Maddison Paul
• THUR 072 A service evaluation of patients attending A&E with seizures (27 September, 2019)

  Fernandopulle Navindi, Yogarajah Mahinda
• THUR 038 Encephalopathy with MRI cortical ribbon and reversible white matter hyperintensities (27 September, 2019)

  Hamish Morrison, Dafydd Morgan, Matthew Smith, Duncan Mclauchlan, Ann Johnston